… fatty liver disease (NAFLD) is currently the most common form of chronic liver disease, … of
these processes may help to identify novel therapeutic targets to treat this disease ( 6 ). A net …

… cytokines. Consequently, the precise role of a single cytokine in human autoimmune diseases
… Despite this difficulty, targeting cytokines in many rheumatic diseases, such as rheumatoid …

… inflammatory pathways in other chronic inflammatory disorders Cytokine blockers (such as
ustekinumab and JAK inhibitors) suppressing cytokine signalling are probably a new addition …

… topics dealing with alcoholic liver disease (ALD), including clinical and translational research.
It focuses on the role of the immune system and the signaling pathways of cytokines in the …

… and SOCS3 are constitutively bound to, is a pivotal cytokine/chemokine generated by the
KCs in response to liver damage that induces inflammation, which is a contributing factor in …

… role cytokines play during disease progression … cytokines and their key roles in atherosclerosis
development they represent promising therapeutic targets in the treatment of this disease. …

… and epigenetic regulation, represent fertile therapeutic targets. New therapies include drugs
… of cytokine and chemokine signaling become clearer, new potential therapeutic targets …

… , obesity, aflatoxin B1 (AFB1) exposure and nonalcoholic fatty liver disease (NAFLD) [4]. …
HGF is a multifunctional cytokine that has been implicated in the invasion of tumor malignancies …

… by liver diseases makes the technique an attractive tool for the measurement of hepatic …
to the role of this cytokine in liver injury, the pathogenic contribution of other proinflammatory …

… at identifying new putative prognostic markers and therapeutic targets of this tumor. Highest
c-myc … cycles of necrosis-liver regeneration foster a chronic liver disease leading to cirrhosis. …